|
|
# 2025 mi-BiomarK |
|
mi-BiomarK is a low-cost, nanomedicine-based diagnostic kit that detects miRNA biomarkers linked to breast cancer from a small blood sample. It eliminates the need for complex equipment by using specially designed probes that trigger a visible colour change when cancer-related miRNAs are present. This non-invasive, affordable approach enables earlier diagnosis, especially in resource-limited settings. By overcoming the limitations of mammography, mi-BiomarK will transform breast cancer screening and improve survival rates through timely detection
Daana Sánchez, a Chemical Analyst Technician and B.A. in Biosciencies from Tecnológico de Monterrey, focuses on biotechnology and molecular diagnostics. With experience in laboratory research and science-based entrepreneurship. Through acceleration programs and the guidance of expert mentors, Daana the mi-BiomarK team drive innovation to develop accessible and impactful diagnostic solutions. Her goal is to improve early breast cancer detection and create positive impact on global health.more
Delft University of Technology – TU Delft
AI-assisted cervical screening for early cancer detection in low-resource settings
